News-Morimatsu LifeSciences

FROM CRITICAL EQUIPMENT TO
TOTAL PROCESS SOLUTION

BACK

From Lab to Table: Morimatsu Drives Cultured Meat Scale-Up

Cultured meat—produced by growing animal cells in vitro—is poised to transform the protein supply chain. It offers a way to reduce reliance on land and water, lower greenhouse gas emissions from traditional livestock farming, and deliver a more sustainable food source. With advancing technology, s
Bidding Farewell to Process Puzzles. Powering Innovative Therapies. Morimatsu Delivers Fully Integrated Biopharmaceutical Solutions

In biopharmaceutical manufacturing, every step—from gene sequence to final product—must work in sync. Yet many companies still rely on equipment from multiple vendors, assembling complex systems piece by piece. The result? Integration challenges, disconnected data, and difficult technology transfe
Invitation Letter | Pharmadule Morimatsu Invites You to Join Us at ANZ Biologics Festival 2026

🎉 We are glad to share that we'll participate in ANZ Biologics Festival 2026！The festival offers a focused, high-level platform for collaboration across R&D, manufacturing, clinical development, scale-up, and commercialisation. 📅 Date: February 4-5, 2026📍 Venue: Crown Promenade Melbou
Invitation Letter | Pharmadule Morimatsu Invites You to Join Us at 2026 ISPE Facilities of the Future Conference

🎊 We are excited to announce our participation in the 2026 ISPE Facilities of the Future Conference！The 2026 ISPE Facilities of the Future Conference agenda features a diverse selection of technical sessions spanning compliance and quality; digital transformation, AI integration, and the future w
Morimatsu MES System Solution Breaking down Data Silos and Powering Digital Transformation in Pharma

As regulatory scrutiny tightens and market competition intensifies, traditional production management models in pharmaceutical manufacturing are showing clear limitations:·Heavy reliance on paper-based records increases the risk of data errors, missing entries, and non-compliant signatures;·

Prev 1 2 3 4 5··· Next